238 related articles for article (PubMed ID: 23248282)
1. Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration.
Chen X; Burdett TC; Desjardins CA; Logan R; Cipriani S; Xu Y; Schwarzschild MA
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):300-5. PubMed ID: 23248282
[TBL] [Abstract][Full Text] [Related]
2. Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.
Cipriani S; Desjardins CA; Burdett TC; Xu Y; Xu K; Schwarzschild MA
PLoS One; 2012; 7(5):e37331. PubMed ID: 22606360
[TBL] [Abstract][Full Text] [Related]
3. A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathy.
Pang L; Liang N; Li C; Merriman TR; Zhang H; Yan F; Sun W; Li R; Xue X; Liu Z; Wang C; Cheng X; Chen S; Yin H; Dalbeth N; Yuan X
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167009. PubMed ID: 38237409
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway.
Gong L; Zhang QL; Zhang N; Hua WY; Huang YX; Di PW; Huang T; Xu XS; Liu CF; Hu LF; Luo WF
J Neurochem; 2012 Dec; 123(5):876-85. PubMed ID: 23094836
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of uric acid, allantoin, and 8-OH-Deoxyguanosine in uricase-knockout mice.
Inazawa K; Yamaguchi S; Hosoyamada M; Fukuuchi T; Tomioka NH; Yamaoka N; Kaneko K
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):559-565. PubMed ID: 27906613
[TBL] [Abstract][Full Text] [Related]
6. Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury.
Hosoyamada M; Tsurumi Y; Hirano H; Tomioka NH; Sekine Y; Morisaki T; Uchida S
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):543-549. PubMed ID: 27906636
[TBL] [Abstract][Full Text] [Related]
7. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
[TBL] [Abstract][Full Text] [Related]
8. Protection of dopaminergic cells by urate requires its accumulation in astrocytes.
Cipriani S; Desjardins CA; Burdett TC; Xu Y; Xu K; Schwarzschild MA
J Neurochem; 2012 Oct; 123(1):172-81. PubMed ID: 22671773
[TBL] [Abstract][Full Text] [Related]
9. Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?
De Luca MA; Cauli O; Morelli M; Simola N
J Neurochem; 2014 Nov; 131(3):284-9. PubMed ID: 24989117
[TBL] [Abstract][Full Text] [Related]
10. The identification of an integral membrane, cytochrome c urate oxidase completes the catalytic repertoire of a therapeutic enzyme.
Doniselli N; Monzeglio E; Dal Palù A; Merli A; Percudani R
Sci Rep; 2015 Sep; 5():13798. PubMed ID: 26349049
[TBL] [Abstract][Full Text] [Related]
11. [Screening, characterization and expression of microbial urate oxidase].
Xian J; Guo X; Li B; Peng H; Wang X; Zhang J; Chen G
Sheng Wu Gong Cheng Xue Bao; 2018 Jul; 34(7):1147-1155. PubMed ID: 30058313
[TBL] [Abstract][Full Text] [Related]
12. Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis.
Lu J; Sun M; Wu X; Yuan X; Liu Z; Qu X; Ji X; Merriman TR; Li C
FEBS J; 2019 Apr; 286(7):1346-1359. PubMed ID: 30690853
[TBL] [Abstract][Full Text] [Related]
13. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
14. Urate oxidase knockdown decreases oxidative stress in a murine hepatic cell line.
Cleveland BM; Leonard SS; Klandorf H; Blemings KP
Oxid Med Cell Longev; 2009; 2(2):93-8. PubMed ID: 20357931
[TBL] [Abstract][Full Text] [Related]
15. Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease.
Kachroo A; Schwarzschild MA
Brain Res; 2014 May; 1563():103-9. PubMed ID: 24680743
[TBL] [Abstract][Full Text] [Related]
16. Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders.
Lu J; Hou X; Yuan X; Cui L; Liu Z; Li X; Ma L; Cheng X; Xin Y; Wang C; Zhang K; Wang X; Ren W; Sun R; Jia Z; Tian Z; Mi QS; Li C
Kidney Int; 2018 Jan; 93(1):69-80. PubMed ID: 28729031
[TBL] [Abstract][Full Text] [Related]
17. Recapture of [S]-allantoin, the product of the two-step degradation of uric acid, by urate oxidase.
Gabison L; Chiadmi M; Colloc'h N; Castro B; El Hajji M; Prangé T
FEBS Lett; 2006 Apr; 580(8):2087-91. PubMed ID: 16545381
[TBL] [Abstract][Full Text] [Related]
18. SIRT5 deacetylates and activates urate oxidase in liver mitochondria of mice.
Nakamura Y; Ogura M; Ogura K; Tanaka D; Inagaki N
FEBS Lett; 2012 Nov; 586(23):4076-81. PubMed ID: 23085393
[TBL] [Abstract][Full Text] [Related]
19. Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease.
Chen X; Umeh CC; Tainsh RE; Feng DD; Maguire M; Zuo F; Rahimian M; Logan R; Wang X; Ascherio A; Macklin EA; Buys ES; Schwarzschild MA;
EBioMedicine; 2018 Nov; 37():259-268. PubMed ID: 30415890
[TBL] [Abstract][Full Text] [Related]
20. Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.
Cipriani S; Chen X; Schwarzschild MA
Biomark Med; 2010 Oct; 4(5):701-12. PubMed ID: 20945982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
